Ausgabe 2/2016
Inhalt (23 Artikel)
Developmental signaling pathways regulating mammary stem cells and contributing to the etiology of triple-negative breast cancer
Maria Cristina Rangel, Daniel Bertolette, Nadia P. Castro, Malgorzata Klauzinska, Frank Cuttitta, David S. Salomon
A comparison of toxicity profiles between the lower and standard dose capecitabine in breast cancer: a systematic review and meta-analysis
Tomohiro F. Nishijima, Maya Suzuki, Hyman B. Muss
Increased CD4 and CD8-positive T cell infiltrate signifies good prognosis in a subset of triple-negative breast cancer
Hirofumi Matsumoto, Aye Aye Thike, Huihua Li, Joe Yeong, Si-lin Koo, Rebecca Alexandra Dent, Puay Hoon Tan, Jabed Iqbal
A novel gene expression signature for bone metastasis in breast carcinomas
C. Dilara Savci-Heijink, Hans Halfwerk, Jan Koster, Marc J. van de Vijver
Effect of ALDH1 on prognosis and chemoresistance by breast cancer subtype
Kumiko Kida, Takashi Ishikawa, Akimitsu Yamada, Kazuhiro Shimada, Kazutaka Narui, Sadatoshi Sugae, Daisuke Shimizu, Mikiko Tanabe, Takeshi Sasaki, Yasushi Ichikawa, Itaru Endo
Is ultrasound-guided fine-needle aspiration cytology of adequate value in detecting breast cancer patients with three or more positive axillary lymph nodes?
G. M. Kramer, M. W. H. Leenders, L. J. Schijf, H. L. S. Go, T. van der Ploeg, M. P. van den Tol, W. H. Schreurs
Equivalence of MammaPrint array types in clinical trials and diagnostics
Inès Beumer, Anke Witteveen, Leonie Delahaye, Diederik Wehkamp, Mireille Snel, Christa Dreezen, John Zheng, Arno Floore, Guido Brink, Bob Chan, Sabine Linn, Rene Bernards, Laura van ’t Veer, Annuska Glas
Adherence to the breast cancer surveillance program for women at risk for familial breast and ovarian cancer versus overscreening: a monocenter study in Germany
Lisa Vetter, Monika Keller, Thomas Bruckner, Michael Golatta, Sabine Eismann, Christina Evers, Nicola Dikow, Christof Sohn, Jörg Heil, Sarah Schott
A phase I/II trial of the safety and clinical activity of a HER2-protein based immunotherapeutic for treating women with HER2-positive metastatic breast cancer
Giuseppe Curigliano, Gilles Romieu, Mario Campone, Thierry Dorval, Lionel Duck, Jean-Luc Canon, Celia Roemer-Becuwe, Mario Roselli, Silvia Neciosup, Wivine Burny, Andrea Callegaro, Pedro Miguel de Sousa Alves, Jamila Louahed, Vincent Brichard, Frédéric F. Lehmann
Should the hyperechogenic halo around malignant breast lesions be included in the measurement of tumor size?
Judith Joekel, Holm Eggemann, Serban Dan Costa, Atanas Ignatov
A non-randomized dose-escalation Phase I trial of a protein-based immunotherapeutic for the treatment of breast cancer patients with HER2-overexpressing tumors
Steven A. Limentani, Mario Campone, Thierry Dorval, Giuseppe Curigliano, Richard de Boer, Charles Vogel, Shane White, Thomas Bachelot, Jean-Luc Canon, Mary Disis, Ahmad Awada, Martine Berlière, Frédéric Amant, Ellis Levine, Wivine Burny, Andrea Callegaro, Pedro Miguel de Sousa Alves, Jamila Louahed, Vincent Brichard, Frédéric F. Lehmann
Revisiting dosing regimen using PK/PD modeling: the MODEL1 phase I/II trial of docetaxel plus epirubicin in metastatic breast cancer patients
Emilie Hénin, Christophe Meille, Dominique Barbolosi, Benoit You, Jérôme Guitton, Athanassios Iliadis, Gilles Freyer
Competing risks of death in women treated with adjuvant aromatase inhibitors for early breast cancer on NCIC CTG MA.27
Judith-Anne W. Chapman, Lois E. Shepherd, James N. Ingle, Hyman B. Muss, Kathleen I. Pritchard, Karen A. Gelmon, Timothy J. Whelan, Catherine Elliott, Paul E. Goss
Investigating racial disparities in use of NK1 receptor antagonists to prevent chemotherapy-induced nausea and vomiting among women with breast cancer
Devon K. Check, Katherine E. Reeder-Hayes, Ethan M. Basch, Leah L. Zullig, Morris Weinberger, Stacie B. Dusetzina
The clinical value of HER-2 overexpression and PIK3CA mutations in the older breast cancer population: a FOCUS study analysis
Charla C. Engels, Mandy Kiderlen, Esther Bastiaannet, Ronald van Eijk, Antien Mooyaart, Vincent T. H. B. M. Smit, Anton J. M. de Craen, Peter J. K. Kuppen, Judith R. Kroep, Cornelis J. H. van de Velde, Gerrit Jan Liefers
The impact of oophorectomy on survival after breast cancer in BRCA1-positive breast cancer patients
T. Huzarski, T. Byrski, J. Gronwald, C. Cybulski, O. Oszurek, M. Szwiec, K. Gugała, M. Stawicka, Z. Morawiec, T. Mierzwa, M. Falco, H. Janiszewska, E. Kilar, E. Marczyk, B. Kozak-Klonowska, M. Siołek, D. Surdyka, R. Wiśniowski, M. Posmyk, P. Domagała, P. Sun, J. Lubiński, S. A. Narod
Effectiveness of bisphosphonate use and risk of contralateral breast cancer and recurrence in women with early-stage breast cancer treated with tamoxifen
Marilyn L. Kwan, Jiaxiao M. Shi, Laurel A. Habel, Jun Song, Joanie W-L Chung, Chantal C. Avila, Joanne E. Schottinger, T. Craig Cheetham, Suzanne W. Fletcher, Reina Haque
Very low local recurrence rates after breast-conserving therapy: analysis of 8485 patients treated over a 28-year period
S. C. J. Bosma, F. van der Leij, E. van Werkhoven, H. Bartelink, J. Wesseling, S. Linn, E. J. Rutgers, M. J. van de Vijver, P. H. M. Elkhuizen
Erratum to: Loss of glucocorticoid receptor activation is a hallmark of BRCA1-mutated breast tissue
Myriam Vilasco, Laudine Communal, Justine Hugon-Rodin, Frédérique Penault-Llorca, Najat Mourra, Zherui Wu, Patricia Forgez, Anne Gompel
Erratum to: Low expression of ULK1 is associated with operable breast cancer progression and is an adverse prognostic marker of survival for patients
Jun Tang, Rong Deng, Rong-Zhen Luo, Guo-Ping Shen, Mu-Yan Cai, Zi-Ming Du, Shan Jiang, Ming-Tian Yang, Jian-Hua Fu, Xiao-Feng Zhu
Erratum to: PI3K/mTOR inhibition can impair tumor invasion and metastasis in vivo despite a lack of antiproliferative action in vitro: implications for targeted therapy
Seth A. Wander, Dekuang Zhao, Alexandra H. Besser, Feng Hong, Jianqin Wei, Tan A. Ince, Clara Milikowski, Nanette H. Bishopric, Andy J. Minn, Chad J. Creighton, Joyce M. Slingerland
Erratum to: RAGE-binding S100A8/A9 promotes the migration and invasion of human breast cancer cells through actin polymerization and epithelial–mesenchymal transition
Chonggao Yin, Hongli Li, Baogang Zhang, Yuqing Liu, Guohua Lu, Shijun Lu, Lei Sun, Yueliang Qi, Xiaolong Li, Weiyi Chen
Erratum to: Estrogen receptor beta binds Sp1 and recruits a corepressor complex to the estrogen receptor alpha gene promoter
V. Bartella, P. Rizza, I. Barone, D. Zito, F. Giordano, C. Giordano, S. Catalano, L. Mauro, D. Sisci, M. L. Panno, S. A. W. Fuqua, S. Andò